Cancer research collaboration between the UK and the USA: reflections on the 2021 G20 Summit announcement.

Abstract

On June 10, 2021, the UK and USA released a joint statement about the visit of US President Joe Biden to the G20 Summit at the invitation of UK Prime Minister Boris Johnson. Within this statement (point 18) is the following: “We will convene the first US–UK Bilateral Cancer Summit and bring together researchers, patients, and other stakeholders to share ideas and identify opportunities for collaboration to accelerate advances in lifesaving approaches to cancer, which remains a leading cause of death worldwide.” 1 The White HouseJoint statement on the visit to the United Kingdom of the Honorable Joseph R. Biden, Jr., President of the United States of America at the invitation of the Rt. Hon. Boris Johnson, M.P., the Prime Minister of the United Kingdom of Great Britain and Northern Ireland. https://www.whitehouse.gov/briefing-room/statements-releases/2021/06/10/joint-statement-on-the-visit-to-the-united-kingdom-of-the-honorable-joseph-r-biden-jr-president-of-the-united-states-of-america-at-the-invitation-of-the-rt-hon-boris-johnson-m-p-the-prime-min/Date: June 10, 2021 Date accessed: February 10, 2022 Google Scholar On Nov 10, 2021, the UK Research and Innovation announced that this Summit would take place on Nov 13–14, 2021, “…to identify transformative research grand challenges and ways to resolve barriers to progress in cancer research.” 2 UK Research and Innovation https://www.ukri.org/news/uk-usa-scientific-summit-to-bolster-cancer-research-collaboration/ Google Scholar Information arising from this meeting is scarce, but we know that several different domains from prevention and early detection to exploring social, economic, and environmental factors that contribute to health inequalities were on the agenda.